1-(17-hydroxy-15,16-dimethoxy-19,21-epoxyaspidospermidin-1-yl)propan-1-one (2122-25-0)

Identification
Name:	1-(17-hydroxy-15,16-dimethoxy-19,21-epoxyaspidospermidin-1-yl)propan-1-one
Synonyms:	Aspidospermidin-17-ol, 19,21-epoxy-15,16-dimethoxy-1-(1-oxopropyl)-
CAS:	2122-25-0
Molecular Formula:	C₂₄H₃₂N₂O₅
Molecular Weight:	428.5213
InChI:	InChI=1/C24H32N2O5/c1-4-18(27)26-17-6-8-22-7-5-11-25-12-9-23(17,24(22,25)31-13-10-22)15-14-16(29-2)21(30-3)20(28)19(15)26/h14,17,28H,4-13H2,1-3H3/t17-,22-,23-,24+/m1/s1
Molecular Structure:
Properties
Flash Point:	362.8°C
Boiling Point:	676.3°C at 760 mmHg
Density:	1.35g/cm³
Refractive index:	1.646
Flash Point:	362.8°C
Safety Data

Other Product

1-(19,21-epoxyaspidospermidin-1-yl)ethanone
1/C19H15ClN2O2S/c1-11-19(23)24-17-18(25-11)22(2)15-9-8-13(20)10-14(15)16(21-17)12-6-4-3-5-7-12/h3-11H,1-2H
1/C18H19NO4/c1-22-15-8-11-10(7-13(15)20)5-12-16-9(3-4-19-12)6-14(21)18(23-2)17(11)16/h6-8,12,19-21H,3-5H2,1-2H
1/C21H26N2O4/c1-3-14-8-9-19(25)23(12-14)11-10-16-15-6-4-5-7-18(15)22-20(16)17(13-24)21(26)27-2/h4-7,12,17,22,24H,3,8-11,13H2,1-2H
1/C26H18O2/c1-17-16-23-21-9-5-3-7-19(21)11-13-25(23)28-26(17)15-14-22-20-8-4-2-6-18(20)10-12-24(22)27-26/h2-16H,1H
1/C22H28O6/c1-23-17-11-21(27-5)19(25-3)9-15(17)13-7-8-14(13)16-10-20(26-4)22(28-6)12-18(16)24-2/h9-14H,7-8H2,1-6H3/t13-,14
1/C17H22N6/c1-2-8-19-13-11-14(23-10-9-18-12-23)20-16-15(13)21-17(22-16)6-4-3-5-7-17/h9-12,19H,2-8H2,1H
Spiro[cyclopentane-1,2'-[9,4](epoxypentadeca[1,11,13]trienimino)[2H]furo[2',3':7,8]naphth[1,2-d]imidazole]-10',26'(9'H)-dione,16'-(acetyloxy)-1',3'-dihydro-5',6',18',20'-tetrahydroxy-14'-methoxy-7',9',15',17',19',21',25'-heptamethyl-,[9'S-(9'R*,12'E,14'R*,15'S*,16'R*,17'S*,18'S*,19'S*,20'R*,21'R*,22'E,24'Z)]-(9CI)
Spiro[cyclohexane-1,2'-[9,4](epoxypentadeca[1,11,- 13]trienimino)[2H]furo[2',3':7,8]naphth[1,2-d]- imidazole]-10',26'(9'H)-dione,16'-(acetyloxy)- 1',3'-dihydro-5',6',18',20'-tetrahydroxy-14'- methoxy-7',9',15',17',19',21',25'-heptamethyl-,(9'S,12'E,14'S,15'R,16'S,17'R,18'R,19'R,20'S,- 21'S,22'E,24'Z)-
3,6,9,12-Tetraoxa-15-azanonadecan-19-oic acid, 1-hydroxy-13-methyl-16-oxo-17-sulfo-, 15-coco alkyl derivs., disodium salts
dynorphin A (1-13), Tyr(14)-Leu(15)-Phe(16)-Asn(17)-Gly(18)-Pro(19)-
1-19-Atrial natriureticpeptide-21 (rat),N-L-arginyl-14-de-L-glutamine-15-de-L-serine-16-deglycine-17-de-L-leucine-18-deglycine-19-L-cysteinamide-(9CI)
1/C20H20N2/c1-4-10-16(11-5-1)18-19(17-12-6-2-7-13-17)22-20(21-18)14-8-3-9-15-20/h1-2,4-7,10-13H,3,8-9,14-15H
1/C14H13N7O/c1-8-12(21-14(17)18-19-20-21)11(9-5-3-2-4-6-9)10(7-15)13(16)22-8/h2-6,11H,16H2,1H3,(H2,17,18,20
1/C17H16N2O3/c1-9(20)12-8-14-15-11(6-7-19(14)17(22)16(12)21)10-4-2-3-5-13(10)18-15/h2-5,8-9,18,20-21H,6-7H2,1H
1/C18H18O6/c1-22-14-8-13(20)15-16(21)11(9-24-18(15)17(14)23-2)7-10-3-5-12(19)6-4-10/h3-6,8,11,19-20H,7,9H2,1-2H
1/C19H20O5/c1-11(2)7-18(21)24-19(3,4)16-9-13-8-12-5-6-17(20)23-14(12)10-15(13)22-16/h5-8,10,16H,9H2,1-4H
1/C18H30O4/c1-4-5-6-7-15(19)13-16(20)10-8-14-9-11-17(21-2)18(12-14)22-3/h9,11-12,15-16,19-20H,4-8,10,13H2,1-3H3/t15-,16-/m0/s
1/C19H24N2O2/c1-12(2)14-8-6-9-15(13(3)4)17(14)21-19(22)18-16(23-5)10-7-11-20-18/h6-13H,1-5H3,(H,21,22
Tricyclo[12.3.1.12,6]nonadeca-1(18),2,4,6(19),10,14,16-heptaen-9-one,17-hydroxy-3,11-dimethoxy-, (10E)-(+)-